Tyrosinase inhibition studies of cycloartane and cucurbitane glycosides and their structure-activity relationships

被引:29
|
作者
Khan, Mahmud Tareq Hassan
Choudhary, M. Iqbal
Atta-ur-Rahman
Mamedova, Reyhan P.
Agzamova, Manzura A.
Sultankhodzhaev, Mukhlis N.
Isaev, Mahamed I.
机构
[1] Univ Sci & Technol, Fac Pharmaceut Sci, Pharmacol Res Lab, Chittagong, Bangladesh
[2] Univ Ferrara, Dept Mol Biol, I-44100 Ferrara, Italy
[3] Univ Karachi, Int Ctr Chem Sci, HEJ Res Inst Chem, Dr Panjwani Ctr Mol Med & Drug Res, Karachi 75270, Pakistan
[4] Acad Sci, S Yunusov Inst Chem Plant Subst, Tashkent, Uzbekistan
关键词
cycloartane; cucurbitane glycoside; Astragalus; Bryonia; tyrosinase inhibition; vitiligo; melanoma;
D O I
10.1016/j.bmc.2006.05.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present paper, tyrosinase inhibition studies and structure-activity relationship of eight cycloartane glycosides and one cucurbitane glycoside and its genin, which were isolated from Astragalus (Leguminoseae) and Bryonia (Cucurbitaceae) plants, have been discussed. The activities are compared with two reference tyrosinase inhibitors, kojic acid and L-mimosine. These studies and the SAR showed that the askendoside B which exhibited highly potent (IC50 = 13.95 mu M) tyrosinase inhibition could be a possible lead molecule for the development of new medications of several skin diseases related with the over-expression of the enzyme tyrosinase, like hyperpigmentation. The molecule also may be interesting for the cosmetic industries as a skin whitening agent. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6085 / 6088
页数:4
相关论文
共 50 条
  • [41] Structure-activity relationships(SAR) studies of CamK II inhibitors
    Kieres, Karolina
    Sala, Marina
    Monterrey, Gomez Isabel
    Bertamino, Alessia
    D'Ursi, Annamaria
    Ilario, Maddalena
    Grieco, Paolo
    Novellino, Ettore
    Campiglia, Pietro
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 87 - 87
  • [42] Mutagenicity studies of benzidine and its analogs: Structure-activity relationships
    Chung, KT
    Chen, SC
    Wong, TY
    Li, YS
    Wei, CI
    Chou, MW
    TOXICOLOGICAL SCIENCES, 2000, 56 (02) : 351 - 356
  • [43] Structure-activity relationships in nitrothiophenes
    Morley, John O.
    Matthews, Thomas P.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (23) : 8099 - 8108
  • [44] STRUCTURE-ACTIVITY RELATIONSHIPS IN TETRACYCLINES
    PALENIK, GJ
    MATHEW, M
    ACTA CRYSTALLOGRAPHICA SECTION A, 1972, 28 : S47 - S47
  • [45] Fuzzy structure-activity relationships
    Luke, BT
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2003, 14 (01) : 41 - 57
  • [46] Methods of studies on quantitative structure-activity relationships for chiral compounds
    Zhang, Qing-You
    Xu, Li-Zhuang
    Li, Jing-Ya
    Zhang, Dan-Dan
    Long, Hai-Lin
    Leng, Ji-Yan
    Xu, Lu
    JOURNAL OF CHEMOMETRICS, 2012, 26 (10) : 497 - 508
  • [47] Structure-activity relationships of various amino-hydroxy-benzenesulfonic acids and sulfonamides as tyrosinase substrates
    Rescigno, Antonio
    Bruyneel, Frederic
    Padiglia, Alessandra
    Sollai, Francesca
    Salis, Andrea
    Marchand-Brynaert, Jaqueline
    Sanjust, Enrico
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2011, 1810 (08): : 799 - 807
  • [48] STRUCTURE-ACTIVITY RELATIONSHIPS IN RIBONUCLEASE
    STEIN, WH
    FEDERATION PROCEEDINGS, 1964, 23 (3P1) : 599 - &
  • [49] STRUCTURE-ACTIVITY RELATIONSHIPS OF ADRENOCORTICOIDS
    RINGLER, I
    MAUER, S
    HEYDER, E
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1961, 107 (02): : 451 - &
  • [50] Structure-activity relationships of untenone A and its derivatives for inhibition of DNA polymerases
    Saito, F
    Takeuchi, R
    Kamino, T
    Kuramochi, K
    Sugawara, F
    Sakaguchi, K
    Kobayashi, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (08) : 1975 - 1977